A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia -: effect on FSH levels and menopausal symptoms

被引:36
|
作者
Halmesmäki, K
Hurskainen, R
Tiitinen, A
Teperi, J
Grenman, S
Kivelä, A
Kujansuu, E
Yliskoski, M
机构
[1] Cent Hosp Paijat Hame, Dept Obstet & Gynecol, Lahti 15850, Finland
[2] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00531, Finland
[3] Hlth Serv Res Unit, Helsinki 00531, Finland
[4] Univ Helsinki, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[5] Hlth Serv Res Unit, Helsinki 00531, Finland
[6] Univ Turku, Dept Obstet & Gynecol, FIN-20520 Turku, Finland
[7] Univ Oulu, Dept Obstet & Gynecol, Oulu 90221, Finland
[8] Univ Tampere, Dept Obstet & Gynecol, Tampere 33521, Finland
[9] Univ Kuopio, Dept Obstet & Gynecol, FIN-70211 Kuopio, Finland
关键词
FSH; hot flushes; hysterectomy; levonorgestrel-releasing intrauterine system; menopausal symptoms;
D O I
10.1093/humrep/deh055
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The purpose of this study was to compare the effects of hysterectomy and a levonorgestrel-releasing intrauterine system (LNG-IUS) on serum FSH levels and menopausal symptoms. METHODS: A total of 236 women referred for menorrhagia to five university hospitals were randomly assigned to treatment with hysterectomy (n = 117) or LNG-IUS (n = 119). Menopausal symptoms were characterized by the Kupperman menopausal distress test. Serum FSH and estradiol levels were measured at baseline and 6 and 12 months after hysterectomy or application of LNG-IUS. Analyses were by intention to treat. RESULTS: After 6 months, there was no difference between the groups, but 12 months after follow-up hysterectomized women had higher FISH levels than women with LNG-IUS (P = 0.005). There was a significant association between PS14 levels and treatment modality (P = 0.020). Hot flushes increased significantly in the hysterectomy group (P = 0.02). There Was a significant association between hot flushes and both treatment modality and age (P = 0.02 and P = 0.01, respectively). CONCLUSION: Hysterectomy may impair ovarian function shown by rising serum FSH levels and hot flushes. However, these results should be interpreted with caution, and longer follow-up is needed.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 50 条
  • [41] Levonorgestrel-releasing intrauterine system vs. endometrial thermal ablation for menorrhagia
    Theodoridis, Theodoros D.
    Zepiridis, Leonidas
    Zafrakas, Menelaos
    Grimbizis, Grigoris
    Tantsis, Antonios
    Kyrou, Dimitra
    Bontis, John N.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2009, 8 (01): : 60 - 64
  • [42] Management of Initial Bleeding or Spotting After Levonorgestrel-Releasing Intrauterine System Placement A Randomized Controlled Trial
    Sordal, Terje
    Inki, Pirjo
    Draeby, John
    O'Flynn, Mary
    Schmelter, Thomas
    OBSTETRICS AND GYNECOLOGY, 2013, 121 (05): : 934 - 941
  • [43] The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia
    Zapico Goni, Alvaro
    Lanzon Lacruz, Ramon
    Parilla Paricio, Juan Jose
    Hernandez Rivas, Francisco J.
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (09) : 581 - 586
  • [44] Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain A Randomized Controlled Trial
    Tanmahasamut, Prasong
    Rattanachaiyanont, Manee
    Angsuwathana, Surasak
    Techatraisak, Kitirat
    Indhavivadhana, Suchada
    Leerasiri, Pichai
    OBSTETRICS AND GYNECOLOGY, 2012, 119 (03): : 519 - 526
  • [45] Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial
    Shabaan, Mamdouh M.
    Zakherah, Mahmoud S.
    El-Nashar, Sherif A.
    Sayed, Gamal H.
    CONTRACEPTION, 2011, 83 (01) : 48 - 54
  • [46] The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: A prospective controlled trial
    Soysal, S
    Soysal, ME
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2005, 59 (01) : 29 - 35
  • [47] Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system
    Li, Lei
    Leng, Jinhua
    Jia, Shuangzheng
    Lang, Jinghe
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 357 - 363
  • [48] A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
    Gupta, Janesh K.
    Daniels, Jane P.
    Middleton, Lee J.
    Pattison, Helen M.
    Prileszky, Gail
    Roberts, Tracy E.
    Sanghera, Sabina
    Barton, Pelham
    Gray, Richard
    Kai, Joe
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (88) : 1 - +
  • [49] The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: A 10-year follow-up of a randomised trial
    Heliovaara-Peippo, S.
    Oksjoki, R.
    Halmesmaki, K.
    Kaaja, R.
    Teperi, J.
    Grenman, S.
    Kivela, A.
    Surcel, H. -M.
    Tomas, E.
    Tuppurainen, M.
    Hurskainen, R.
    Paavonen, J.
    MATURITAS, 2011, 69 (04) : 354 - 358
  • [50] Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study
    Chen, Yi-Jen
    Hsu, Teh-Fu
    Huang, Ben-Shian
    Tsai, Hsiao-Wen
    Chang, Yen-Hou
    Wang, Peng-Hui
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (06) : 582.e1 - 582.e9